Disior
Financials
Estimates*
EUR | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|---|
Revenues | <1m | <1m | - | <1m | <1m | <1m |
% growth | - | 144 % | - | - | 183 % | 37 % |
EBITDA | (<1m) | (<1m) | (<1m) | (<1m) | (<1m) | (1.5m) |
% EBITDA margin | (733 %) | (605 %) | - | (1270 %) | (398 %) | (870 %) |
Profit | (<1m) | (<1m) | (<1m) | (<1m) | (1.0m) | (1.8m) |
% profit margin | (850 %) | (811 %) | - | (1891 %) | (781 %) | (1037 %) |
R&D budget | <1m | <1m | <1m | <1m | - | - |
R&D % of revenue | 1111 % | 909 % | - | 1087 % | - | - |
Source: Dealroom estimates
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
€200k | Seed | ||
* | €600k | Seed | |
€1.7m | Seed | ||
* | N/A | Acquisition | |
Total Funding | AUD4.3m |
Related Content
Recent News about Disior
EditDisior develops advanced 3D medical imaging software tailored for clinicians, focusing on automated segmentation and detailed anatomical analysis. The software significantly reduces the time and effort required for manual segmentation, providing accurate 3D analysis of human anatomies within minutes. This technology is particularly beneficial for orthopedic analysis and is compatible with CT, CBCT, and WBCT scans. Clinicians can easily transfer DICOM and 3D data, simulate procedures, and assess post-operative measures to improve treatment outcomes. The software also offers automated analytics for various anatomical structures, enhancing diagnostic accuracy and patient throughput. Disior's business model revolves around selling its software solutions to healthcare providers, hospitals, and clinics, generating revenue through software licenses and subscriptions. The company operates in the medical imaging market, serving a wide range of clients from individual practitioners to large healthcare institutions.
Keywords: 3D imaging, medical software, automated segmentation, anatomical analysis, orthopedic, CT scans, CBCT, DICOM transfer, patient-specific surgery, healthcare technology.